Analysts Remain Bullish on Gossamer Bio (GOSS) Despite Phase 3 Setback

Gossamer Bio, Inc. (NASDAQ:GOSS) earns a spot connected our database of the best penny stocks acceptable to explode.

As of April 8, 2026, sentiment astir Gossamer Bio, Inc. (NASDAQ:GOSS) remains cautious, with 56% of covering analysts issuing “Hold” ratings connected the stock. The statement terms people of $1 implies an upside of 203.31%.

Gossamer Bio, Inc. (NASDAQ:GOSS) drew attraction from analysts pursuing its Q4 and full-year 2025 net release.

On March 23, 2026, Cantor Fitzgerald lowered Gossamer Bio, Inc. (NASDAQ:GOSS) from “Overweight” to “Neutral,” pursuing the unsatisfactory Phase 3 PROSERA readout. The terms people simplification came due to the fact that of an progressively uncertain regulatory way for seralutinib successful pulmonary arterial hypertension, which the expert said was excessively unclear to warrant condemnation successful commercialization.

This cautionary attack was noted successful Gossamer’s fourth-quarter and full-year 2025 update connected March 17, 2026, wherever absorption said it was reviewing the PROSERA dataset, engaging with the FDA, and reevaluating its strategy and superior allocation.

Seralutinib showed a placebo-adjusted 6MWD betterment of 13.3 meters successful Week 24, on with stronger signals successful definite subgroups. However, the survey failed to conscionable its prespecified alpha threshold.

Additionally, Gossamer Bio, Inc. (NASDAQ:GOSS) halted enrollment successful PH-ILD’s Phase 3 SERANATA survey and reported $136.9 cardinal successful cash, currency equivalents, and marketable securities arsenic of the extremity of 2025, with the anticipation that it volition money operations into Q1 of 2027.

Gossamer Bio, Inc. (NASDAQ:GOSS) is simply a pharmaceutical institution specializing successful the discovery, development, and selling of treatments successful the aesculapian fields of immunology, inflammation, and oncology.

While we admit the imaginable of GOSS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.